ANEW MEDICAL Receives Notification of Issuance of Alzheimer’s Gene Therapy Patent and Claims by the European Patent Organization (EPO)

ANEW MEDICAL, INC., a technology and medical product holding company (OTC: LEAS) (“ANEW” or the “Company”) received notification by the EPO of its intention to grant a patent titled “Secreted Splicing Variant of Mammalian Klotho as a Medicament for Cognition and Behaviour Impairments” to Universitat Autonomous De Barcelona (UAB) and Institucio Catalana De Recerca Estudis Avancats (ICREA) of Barcelona, Spain. The technology was licensed on an exclusive worldwide basis in 2022 from UAB and ICREA by ANEW MEDICAL. Continue reading